Conditions are improving, says Mr Vasella, and are now tolerable, if not ideal.

"Healthcare reform in China means more growth in our operations, while in other countries it means less," said Mr Vasella.

And since drugs take such a long time to develop, Mr Vasella believes intellectual-property protection will be sufficient by the time the research laboratory produces its first fruits.